Synthesis and structure-activity relationships of USP48 deubiquitinylase inhibitors

被引:1
|
作者
Boehm, Kevin [1 ,2 ]
Schulze-Niemand, Eric [1 ]
Kaehne, Thilo [1 ]
Siddiqui, Elisa [1 ]
Taeger, Christian [1 ]
Ramsbeck, Daniel [2 ]
Buchholz, Mirko [2 ]
Naumann, Michael [1 ,3 ,4 ]
机构
[1] Otto Guericke Univ, Inst Expt Internal Med, Magdeburg, Germany
[2] Fraunhofer Inst Cell Therapy & Immunol IZI, Dept Drug Design & Target Validat MWT, Bioctr, Halle, Germany
[3] Otto Guericke Univ, Inst Expt Internal Med, Med Fac, Leipziger Str 44, D-39120 Magdeburg, Germany
[4] PerioTrap Pharmaceut GmbH, Bioctr, Halle, Germany
关键词
chemical synthesis; drug design; papain-like protease; ubiquitin-specific proteases; USP2; SMALL-MOLECULE INHIBITOR; UBIQUITIN; SPECIFICITY; DISCOVERY; CELLS;
D O I
10.1002/ardp.202200661
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ubiquitin-specific proteases represent a family of enzymes that catalyze the cleavage of ubiquitin from specific substrate proteins to regulate their activity. USP48 is a rarely studied USP, which has recently been linked to inflammatory signaling via regulation of the transcription factor nuclear factor kappa B. Nonetheless, a crystal structure of USP48 has not yet been resolved and potent inhibitors are not known. We screened a set of 14 commercially available USP inhibitors for their activity against USP48 and identified the USP2 inhibitor "ML364" as a candidate for further optimization. Using a ligand-based approach, we derived and synthesized a series of ML364 analogs. The IC50 concentrations of the new compounds to inhibit USP48 were determined in a deubiquitinylase activity assay by measuring the fluorescence intensity using tetra-ubiquitin rhodamine110 as substrate. A compound containing a carboxylic acid functionalization (17e) inhibited USP48 activity toward tetra-ubiquitin rhodamine110 with an IC50 of 12.6 mu M. Further structure-based refinements are required to improve the inhibition activity and specificity.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Structure-activity relationships for synthetic peptide inhibitors of thrombin
    Clement, CC
    Gingold, J
    Philipp, M
    FASEB JOURNAL, 2003, 17 (05): : A1006 - A1006
  • [42] An Overview of Thrombin Inhibitors in the Perspective of Structure-activity Relationships
    Wang, Jiangming
    Sun, Xiaojing
    Li, Na
    Sheng, Ruilong
    Guo, Ruihua
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (25) : 2864 - 2930
  • [43] Inhibitors of vitamin D hydroxylases: Structure-activity relationships
    Schuster, I
    Egger, H
    Nussbaumer, P
    Kroemer, RT
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 88 (02) : 372 - 380
  • [44] Structure-activity relationships of carbocyclic influenza neuraminidase inhibitors
    Williams, MA
    Lew, W
    Mendel, DB
    Tai, CY
    Escarpe, PA
    Laver, WG
    Stevens, RC
    Kim, CU
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (14) : 1837 - 1842
  • [45] Structure-activity relationships of novel potent MurF inhibitors
    Gu, YG
    Florjancic, AS
    Clark, RF
    Zhang, TY
    Cooper, CS
    Anderson, DD
    Lerner, CG
    McCall, JO
    Cai, YN
    Black-Schaefer, CL
    Stamper, GF
    Hajduk, PJ
    Beutel, BA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) : 267 - 270
  • [46] The development of novel telomerase inhibitors: Structure-activity relationships
    Cheng, MK
    Modi, C
    Grindon, CR
    Stevens, MFG
    Laughton, CA
    BRITISH JOURNAL OF CANCER, 2003, 88 : S40 - S40
  • [47] Structure-activity relationships of PDE5 inhibitors
    Eros, D.
    Szantai-Kis, Cs.
    Kiss, R.
    Keri, Gy.
    Hegymegi-Barakonyi, B.
    Koevesdi, I.
    Orfi, L.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (16) : 1570 - 1585
  • [48] Structure-activity relationships of some complex I inhibitors
    Miyoshi, H
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1998, 1364 (02): : 236 - 244
  • [49] STRUCTURE-ACTIVITY RELATIONSHIPS OF MONOAMINE-OXIDASE INHIBITORS
    FUJITA, T
    JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (08) : 923 - 930
  • [50] Synthesis and structure-activity relationships of bengazole A analogs
    Mulder, Roger J.
    Shafer, Cynthia M.
    Dalisay, Doralyn S.
    Molinski, Tadeusz F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (11) : 2928 - 2930